Oxbow Advisors LLC Purchases New Holdings in Corteva, Inc. $CTVA

Oxbow Advisors LLC bought a new position in Corteva, Inc. (NYSE:CTVA) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 96,303 shares of the company’s stock, valued at approximately $8,156,000.

A number of other institutional investors have also recently made changes to their positions in CTVA. Elevation Wealth Partners LLC boosted its stake in Corteva by 334.6% during the 2nd quarter. Elevation Wealth Partners LLC now owns 339 shares of the company’s stock valued at $29,000 after purchasing an additional 261 shares during the last quarter. Clearstead Trust LLC purchased a new position in shares of Corteva in the second quarter worth $31,000. JPL Wealth Management LLC bought a new position in shares of Corteva during the third quarter valued at $25,000. N.E.W. Advisory Services LLC bought a new position in shares of Corteva during the second quarter valued at $33,000. Finally, Westfuller Advisors LLC boosted its position in shares of Corteva by 2,764.3% during the first quarter. Westfuller Advisors LLC now owns 401 shares of the company’s stock valued at $34,000 after buying an additional 387 shares during the last quarter. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on CTVA shares. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $101.00 price target on shares of Corteva in a research note on Monday, August 3rd. Weiss Ratings downgraded shares of Corteva from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday, August 3rd. UBS Group dropped their target price on shares of Corteva from $89.00 to $85.00 and set a “neutral” rating on the stock in a report on Tuesday. Bank of America lifted their target price on shares of Corteva from $90.00 to $96.00 and gave the stock a “buy” rating in a research report on Monday, July 20th. Finally, Citigroup increased their price target on Corteva from $85.00 to $86.00 and gave the company a “neutral” rating in a report on Monday, August 3rd. Fourteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $91.50.

Corteva Trading Up 2.6%

Shares of NYSE:CTVA opened at $77.97 on Wednesday. The stock has a 50 day moving average of $81.84 and a 200 day moving average of $80.12. The company has a market cap of $52.02 billion, a PE ratio of 51.64, a price-to-earnings-growth ratio of 2.35 and a beta of 0.57. Corteva, Inc. has a 12-month low of $60.53 and a 12-month high of $90.97. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Thursday, July 30th. The company reported $2.30 EPS for the quarter, beating the consensus estimate of $2.24 by $0.06. The firm had revenue of $6.38 billion for the quarter, compared to the consensus estimate of $6.60 billion. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The company’s revenue was down 1.2% on a year-over-year basis. During the same period last year, the firm earned $2.20 EPS. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. As a group, equities research analysts expect that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be paid a dividend of $0.18 per share. The ex-dividend date of this dividend is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s dividend payout ratio is presently 47.68%.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.